RMD ResMed Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

RMD [NYSE]

ResMed Inc.

Healthcare | Medical Instruments & Supplies | USA

statements

Index	S&P 500	P/E	41.40	EPS (ttm)	4.27	Insider Own	0.50%	Shs Outstand	144.64M	Perf Week	2.04%
Market Cap	25.91B	Forward P/E	34.19	EPS next Y	5.17	Insider Trans	-10.15%	Shs Float	143.55M	Perf Month	-9.72%
Income	621.70M	PEG	1.96	EPS next Q	0.99	Inst Own	71.90%	Short Float	1.23%	Perf Quarter	7.71%
Sales	2.96B	P/S	8.76	EPS this Y	-9.60%	Inst Trans	2.75%	Short Ratio	2.57	Perf Half Y	0.10%
Book/sh	15.60	P/B	11.33	EPS next Y	9.95%	ROA	10.50%	Target Price	184.00	Perf Year	33.59%
Cash/sh	2.41	P/C	73.42	EPS next 5Y	21.10%	ROE	20.80%	52W Range	108.85 - 208.99	Perf YTD	14.07%
Dividend	1.56	P/FCF	123.15	EPS past 5Y	3.50%	ROI	13.70%	52W High	-15.41%	Beta	0.42
Dividend %	0.88%	Quick Ratio	2.00	Sales past 5Y	10.90%	Gross Margin	58.50%	52W Low	62.41%	ATR	5.26
Employees	7240	Current Ratio	2.70	Sales Q/Q	16.20%	Oper. Margin	21.90%	RSI (14)	36.75	Volatility	1.94% 2.30%
Optionable	Yes	Debt/Eq	0.61	EPS Q/Q	53.30%	Profit Margin	15.30%	Rel Volume	0.68	Prev Close	177.51
Shortable	Yes	LT Debt/Eq	0.60	Earnings	Aug 05 AMC	Payout	48.00%	Avg Volume	684.63K	Price	176.78
Recom	3.00	SMA20	-9.23%	SMA50	-4.92%	SMA200	7.82%	Volume	468,720	Change	-0.41%

Aug-07-20

Downgrade

Morgan Stanley

Overweight → Equal-Weight

Jun-17-20

Upgrade

Morgan Stanley

Equal-Weight → Overweight

May-01-20

Upgrade

Oppenheimer

Perform → Outperform

$200

May-01-20

Downgrade

JP Morgan

Neutral → Underweight

Feb-18-20

Downgrade

Morgan Stanley

Overweight → Equal-Weight

Feb-03-20

Initiated

CLSA

Underperform

Jan-31-20

Downgrade

UBS

Buy → Neutral

$150 → $174

Jan-10-20

Initiated

Oppenheimer

Perform

Nov-22-19

Initiated

KeyBanc Capital Markets

Sector Weight

Jul-29-19

Upgrade

UBS

Neutral → Buy

$122 → $140

Jul-16-19

Downgrade

UBS

Buy → Neutral

May-06-19

Upgrade

UBS

Neutral → Buy

$109 → $119

Apr-18-19

Upgrade

JP Morgan

Underweight → Neutral

$95

Jan-25-19

Downgrade

JP Morgan

Neutral → Underweight

Jan-25-19

Downgrade

Goldman

Buy → Neutral

Oct-26-18

Upgrade

Credit Suisse

Neutral → Outperform

Jul-02-18

Initiated

Goldman

Buy

Apr-04-18

Downgrade

Citigroup

Buy → Neutral

Jan-23-18

Upgrade

Northland Capital

Under Perform → Market Perform

Jan-23-18

Upgrade

Needham

Underperform → Hold

Aug-14-20 05:48AM	ResMed Inc (RMD) Files 10-K for the Fiscal Year Ended on June 30, 2020 GuruFocus.com
03:48AM	ResMed Inc (RMD) Files 10-K for the Fiscal Year Ended on June 30, 2020 GuruFocus.com
02:48AM	ResMed Inc (RMD) Files 10-K for the Fiscal Year Ended on June 30, 2020 GuruFocus.com
12:48AM	ResMed Inc (RMD) Files 10-K for the Fiscal Year Ended on June 30, 2020 GuruFocus.com
Aug-13-20 11:48PM	ResMed Inc (RMD) Files 10-K for the Fiscal Year Ended on June 30, 2020 GuruFocus.com
05:48PM	ResMed Inc (RMD) Files 10-K for the Fiscal Year Ended on June 30, 2020 GuruFocus.com
04:33PM	ResMed Inc (RMD) Files 10-K for the Fiscal Year Ended on June 30, 2020 GuruFocus.com
Aug-11-20 10:00AM	VIDA appoints digital health technology leader Karen Drexler to board of directors, underscoring focus on market expansion of AI solutions PR Newswire
Aug-06-20 09:57AM	ResMed (RMD) Q4 Earnings & Revenues Top Estimates, Margins Up Zacks -13.52%
Aug-05-20 05:25PM	ResMed (RMD) Q4 Earnings and Revenues Surpass Estimates Zacks
04:05PM	ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2020 Business Wire
Aug-04-20 12:02PM	Medical Products Stock Earnings on Aug 5: RMD, ABC & More Zacks
11:17AM	3 Medical Product Stocks Set to Beat This Earnings Season Zacks
09:26AM	Is a Surprise Coming for ResMed (RMD) This Earnings Season? Zacks
Aug-03-20 12:10PM	Can ResMed (RMD) Keep the Earnings Surprise Streak Alive? Zacks
Aug-02-20 10:59AM	Here's What ResMed Inc.'s (NYSE:RMD) Shareholder Ownership Structure Looks Like Simply Wall St.
Jul-29-20 12:33PM	ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth Zacks
Jul-28-20 11:30AM	Has ResMed (RMD) Outpaced Other Medical Stocks This Year? Zacks
Jul-21-20 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook ResMed (RMD) Zacks
Jul-16-20 09:15AM	ResMed (RMD) Hits 52-Week High, Can the Run Continue? Zacks
Jul-15-20 04:30PM	ResMed to Report Fourth Quarter Fiscal 2020 Earnings on August 5, 2020 Business Wire
Jul-14-20 11:45AM	Crowded trade, high valuations: why investors worry about tech stocks Reuters
Jul-10-20 06:09PM	Did Hedge Funds Make The Right Call On ResMed Inc. (RMD) ? Insider Monkey
Jul-02-20 12:45PM	Here is Why Growth Investors Should Buy ResMed (RMD) Now Zacks
08:47AM	Sustainable Investment Forms Part of the New Normal: 5 Picks Zacks
Jun-30-20 09:23AM	Best Dividend Stocks for July 2020 Investopedia
Jun-25-20 12:35PM	Here's Why You Should Hold on to ResMed (RMD) Stock for Now Zacks
Jun-19-20 12:44PM	Nasdaq Tops 10,000 But Sinks After Apple Closes Some Stores On Covid-19 Resurgence Investor's Business Daily
12:01PM	Nasdaq Tops 10,000 In Broad Gains For Stocks; IBD 50 Outperforms Investor's Business Daily
Jun-17-20 07:11AM	3 MedTech Stocks to Watch Amid Coronavirus Catastrophe Zacks
Jun-15-20 09:13AM	Ventilator Industry Pumps Up Amid Coronavirus: 3 Stocks in Focus Zacks
Jun-10-20 02:08PM	P/E Ratio Insights for ResMed Benzinga
Jun-03-20 11:20AM	Hedge Funds Have Never Been This Bullish On ResMed Inc. (RMD) Insider Monkey
09:00AM	ResMed Announces Participation in the William Blair 40th Annual Growth Stock Conference Business Wire
May-30-20 11:31AM	ResMed (RMD) Up 3.5% Since Last Earnings Report: Can It Continue? Zacks
May-28-20 01:33PM	Thursday Morning Market Highlights GuruFocus.com
May-27-20 10:10PM	Rugby League Legend Brad Fittler Teams Up with ResMed to Help Australians Sleep Better Business Wire
01:07PM	Wednesday Morning Market Highlights GuruFocus.com
May-26-20 08:00AM	Propeller Health Receives FDA Clearance to Connect Patients Using the Symbicort® Inhaler to its Digital Health Platform Business Wire
May-20-20 09:00AM	MatrixCare Celebrates Post-acute Healthcare Workers with National Heroes Program Business Wire
May-19-20 10:47AM	ResMed (RMD) Launches Digital Tool for Remote Mask Selection Zacks
10:25AM	Here's Why You Should Hold on to ResMed (RMD) Stock for Now Zacks
May-18-20 09:00AM	ResMed Debuts MaskSelector, a Digital Tool for Remote CPAP Mask Fittings Business Wire
May-15-20 10:42AM	ResMed Grows on Solid Ventilator Sales Amid Coronavirus Woes Zacks
May-11-20 04:18PM	S&P 500 and Nasdaq Gain on Monday GuruFocus.com
10:44AM	Don't Sleep On ResMed Investor's Business Daily Video
May-07-20 02:13PM	Edited Transcript of RMD earnings conference call or presentation 30-Apr-20 8:30pm GMT Thomson Reuters StreetEvents
May-06-20 01:47PM	Were Hedge Funds Right About ResMed Inc. (RMD)? Insider Monkey
09:00AM	ResMed Announces Participation in the Bank of America Merrill Lynch Global Healthcare Conference Business Wire
May-05-20 03:00AM	ResMed Accelerates Release of Ventilator Telemonitoring Platform to Enable Safer, More Efficient Patient Care Business Wire
May-04-20 06:00AM	U.S. arms makers and medical device firms team up to make ventilators Reuters
May-01-20 06:20PM	Company Profile for ResMed Business Wire
02:31AM	Resmed Inc (RMD) Q3 2020 Earnings Call Transcript Motley Fool
Apr-30-20 06:06PM	ResMed stock rises as earnings beat on ventilator production MarketWatch
04:05PM	ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2020 Business Wire
Apr-29-20 11:09AM	Medical Products Stock Earnings on Apr 30: BAX, IDXX & More Zacks
Apr-28-20 11:30AM	Is ResMed (RMD) Stock Outpacing Its Medical Peers This Year? Zacks
Apr-27-20 10:05AM	Zacks.com featured highlights include: Keysight Technologies, ResMed, Cigna and Jack Henry & Associates Zacks
08:28AM	AMN Healthcare Inks Deal to Address Healthcare System Needs Zacks
Apr-24-20 09:48AM	Add These 4 GARP Stocks to Your Portfolio for Maximum Returns Zacks
Apr-23-20 12:32PM	ResMed (RMD) Earnings Expected to Grow: Should You Buy? Zacks
10:30AM	ResMed (RMD) Q3 Earnings to Gain From Growing Ventilator Sales Zacks
Apr-22-20 03:36PM	How the $484B stimulus bill will impact the healthcare sector Yahoo Finance Video
Apr-21-20 02:20PM	IBD 50 Stocks To Watch: ResMed Ramps Up Ventilator Production For Coronavirus Patients Investor's Business Daily
12:03PM	Here's Why You Should Add Tandem Diabetes to Your Portfolio Zacks
07:22AM	Pacific Biosciences' Sequel II Gets Acquired by inqaba biotec Zacks
Apr-20-20 06:45PM	U.S. revs up ventilator production for coronavirus patients as need wanes Reuters
09:26AM	What Is ResMed's (NYSE:RMD) P/E Ratio After Its Share Price Rocketed? Simply Wall St.
08:27AM	Here's Why You Should Retain Accuray in Your Portfolio Zacks
Apr-16-20 11:00AM	Zacks.com featured highlights include: Regency Centers, ResMed, Synopsys, Cboe Global Markets and The Southern Company Zacks
Apr-15-20 11:45AM	The stock market has been on a roller coaster for 2 months but the S&P 500 is down only 2% over 12 months. Here are the big winners. MarketWatch
09:33AM	QIAGEN (QGEN) Reports Preliminary Revenue Results for Q1 Zacks
08:57AM	Illumina (ILMN) Posts Q1 Preliminary Results, Withdraws View Zacks
08:26AM	Intersect Posts Preliminary Q1 Results, Withdraws '20 View Zacks
Apr-14-20 09:56AM	Here's Why You Should Add ResMed (RMD) in Your Portfolio Zacks
09:38AM	ResMed (RMD) Grows on Stellar Mask Sales, SaaS Capabilities Zacks
Apr-13-20 11:14AM	Asthma Hospitalizations Dropped after Louisville Power Plants Retired Coal or Installed Better Emission Controls Business Wire
Apr-09-20 04:05PM	ResMed to Report Third Quarter Fiscal 2020 Earnings on April 30, 2020 Business Wire
09:35AM	Bio-Rad Rides on International Expansion Amid Cost Concerns Zacks
Apr-08-20 09:12AM	Medtronic (MDT) Demonstrates Global Growth Amid Cost Concerns Zacks
Apr-07-20 09:01PM	The World Needs Ventilators. Here's the Snag Bloomberg
11:30AM	Has ResMed (RMD) Outpaced Other Medical Stocks This Year? Zacks
09:30AM	Here's Why You Should Hold on to Thermo Fisher (TMO) for Now Zacks
09:18AM	Product Launches Aid Hill-Rom Amid Project Timing Issues Zacks
07:15AM	Merit Medical WRAPSODY Gets 2 FDA Breakthrough Device Nods Zacks
Apr-03-20 09:30AM	IDEXX's (IDXX) CAG Arm Grows Strong on Product Launches Zacks
Apr-02-20 09:58PM	ResMed Statement on DPA Business Wire +5.51%
03:37PM	Trump invokes Defense Production Act for ventilator manufacturing Reuters
10:04AM	Walgreens Boots (WBA) Q2 Earnings Top Estimates, Margins Down Zacks
08:19AM	ResMed's Strong Charts Tell Bullish Story in Down Market TheStreet.com
06:56AM	Tesla Can Help With Lithium-Ion Batteries For Its Ventilators, Says ResMed's CEO Benzinga
Apr-01-20 12:59PM	3 Must-Buy Stocks as Coronavirus Cases Spike (Revised) Zacks
09:41AM	Bruker (BRKR) Q4 Earnings Miss Estimates, Revenues Beat Zacks
Mar-31-20 12:38PM	The Zacks Analyst Blog Highlights: General Motors, Tesla, Cardinal Health, ResMed and Medtronic Zacks
08:56AM	STERIS' (STE) Organic Growth Robust Amid Bottom-Line Hurdles Zacks
Mar-30-20 12:18PM	4 MedTech Stocks Set to Rebound Post Coronavirus-Led Crisis Zacks +8.64%
12:09PM	Syneos Health Launches Initiative for COVID-19 Patients Zacks
11:06AM	3 Must-Buy Stocks as Coronavirus Cases Spike Zacks
Mar-29-20 11:46AM	Soaring demand for ventilators creates political tension, promises to ramp up manufacturing MarketWatch
Mar-27-20 03:21PM	Gov. Cuomo renews call for ventilators as Elon Musk pledges to provide hundreds to New York MarketWatch

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software solutions that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates through two segments, Sleep and Respiratory Care, and Software as a Service (SaaS). It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides humidifiers, carry bags, and breathing circuits; data communications and control products, such as AirView Diagnostics, EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules; U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as S+, connectivity module, and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and healthcare-first and matrixcare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 120 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PENDARVIS DAVID	Chief Administrative Officer	Aug 03	Option Exercise	57.76	5,919	341,881	139,081	Aug 04 08:01 PM
Sodhi Rajwant	President, SaaS Business	Aug 03	Sale	200.06	1,500	300,090	28,261	Aug 04 05:13 PM
PENDARVIS DAVID	Chief Administrative Officer	Aug 03	Sale	201.99	5,919	1,195,593	133,162	Aug 04 08:01 PM
Hollingshead James	President, Sleep Business	Aug 03	Sale	202.02	2,400	484,854	87,474	Aug 04 05:32 PM
Sandercock Brett	Chief Financial Officer	Jul 15	Sale	196.98	2,500	492,450	84,796	Jul 17 09:26 PM
Douglas Robert Andrew	President and COO ResMed Inc.	Jul 15	Sale	196.98	1,026	202,101	185,717	Jul 17 11:27 AM
PENDARVIS DAVID	Chief Administrative Officer	Jul 06	Option Exercise	57.76	5,919	341,881	139,861	Jul 07 03:14 PM
PENDARVIS DAVID	Chief Administrative Officer	Jul 06	Sale	194.64	5,919	1,152,090	133,942	Jul 07 03:14 PM
Hollingshead James	President, Sleep Business	Jul 01	Sale	189.63	2,400	455,112	89,874	Jul 06 11:14 AM
Sodhi Rajwant	President, SaaS Business	Jul 01	Sale	189.49	1,500	284,235	29,761	Jul 02 02:15 PM
Douglas Robert Andrew	President and COO ResMed Inc.	Jun 15	Sale	158.79	1,245	197,694	186,743	Jun 16 07:45 PM
Sandercock Brett	Chief Financial Officer	Jun 15	Sale	158.79	2,500	396,975	87,296	Jun 16 07:43 PM
PENDARVIS DAVID	Chief Administrative Officer	Jun 03	Option Exercise	57.76	5,919	341,881	136,322	Jun 05 12:32 PM
PENDARVIS DAVID	Chief Administrative Officer	Jun 03	Sale	160.61	5,919	950,660	130,403	Jun 05 12:32 PM
Sodhi Rajwant	President, SaaS Business	Jun 01	Sale	160.13	1,500	240,195	31,261	Jun 02 06:22 PM
Hollingshead James	President, Sleep Business	Jun 01	Sale	160.13	1,200	192,156	92,274	Jun 02 07:46 PM
Douglas Robert Andrew	President and COO ResMed Inc.	May 15	Sale	162.05	1,228	198,997	187,988	May 19 12:55 PM
Sandercock Brett	Chief Financial Officer	May 15	Sale	162.05	2,500	405,125	89,796	May 19 10:17 AM
PENDARVIS DAVID	Chief Administrative Officer	May 04	Option Exercise	58.24	4,737	275,883	135,379	May 06 04:31 PM
PENDARVIS DAVID	Chief Administrative Officer	May 04	Sale	155.06	4,737	734,515	130,642	May 06 04:31 PM
Hollingshead James	President, Sleep Business	May 01	Sale	164.00	1,200	196,800	93,365	May 05 12:44 PM
Sodhi Rajwant	President, SaaS Business	May 01	Sale	164.00	1,500	246,000	32,670	May 05 12:56 PM
Douglas Robert Andrew	President and COO ResMed Inc.	Apr 15	Sale	159.03	1,222	194,335	189,216	Apr 16 07:13 PM
Sandercock Brett	Chief Financial Officer	Apr 15	Sale	159.03	2,500	397,575	92,211	Apr 16 07:00 PM
PENDARVIS DAVID	Chief Administrative Officer	Apr 03	Option Exercise	58.24	4,739	275,999	135,303	Apr 06 08:38 PM
PENDARVIS DAVID	Chief Administrative Officer	Apr 03	Sale	152.63	4,739	723,303	130,564	Apr 06 08:38 PM
Hollingshead James	President, Sleep Business	Apr 02	Sale	150.00	1,200	180,000	94,565	Apr 03 04:25 PM
Sodhi Rajwant	President, SaaS Business	Apr 01	Sale	140.73	1,500	211,095	34,170	Apr 03 02:46 PM
Douglas Robert Andrew	President and COO ResMed Inc.	Mar 16	Sale	137.49	1,336	183,687	190,438	Mar 17 05:16 PM
Sandercock Brett	Chief Financial Officer	Mar 16	Sale	137.49	2,500	343,725	94,711	Mar 17 05:18 PM
PENDARVIS DAVID	Chief Administrative Officer	Mar 03	Option Exercise	58.24	4,739	275,999	135,303	Mar 05 02:33 PM
PENDARVIS DAVID	Chief Administrative Officer	Mar 03	Sale	166.65	4,739	789,757	130,564	Mar 05 02:33 PM
Hollingshead James	President, Sleep Business	Mar 02	Sale	160.50	1,200	192,600	95,765	Mar 03 04:15 PM
Burt Carol	Director	Mar 02	Sale	164.90	10,000	1,648,954	13,478	Mar 03 05:19 PM
Sodhi Rajwant	President, SaaS Business	Mar 02	Sale	160.50	1,500	240,750	35,670	Mar 03 02:31 PM
Douglas Robert Andrew	President and COO ResMed Inc.	Feb 18	Sale	176.14	1,133	199,567	191,774	Feb 19 04:10 PM
Sandercock Brett	Chief Financial Officer	Feb 18	Sale	176.14	2,500	440,350	97,211	Feb 19 02:32 PM
Farrell Michael J.	Chief Executive Officer	Feb 10	Option Exercise	43.63	6,647	290,009	361,347	Feb 12 12:32 PM
McHale Richard	President, RC Business	Feb 10	Sale	172.63	3,000	517,904	17,670	Feb 12 04:24 PM
Farrell Michael J.	Chief Executive Officer	Feb 10	Sale	172.21	6,647	1,144,663	354,700	Feb 12 12:32 PM
PENDARVIS DAVID	Chief Administrative Officer	Feb 03	Option Exercise	58.24	4,739	275,999	135,303	Feb 05 01:48 PM
PENDARVIS DAVID	Chief Administrative Officer	Feb 03	Sale	162.37	4,739	769,469	130,564	Feb 05 01:48 PM
Sodhi Rajwant	President, SaaS Business	Feb 03	Sale	159.46	1,350	215,271	37,170	Feb 05 01:25 PM
Hollingshead James	President, Sleep Business	Feb 03	Sale	159.46	1,200	191,352	91,974	Feb 05 01:22 PM
Sandercock Brett	Chief Financial Officer	Jan 15	Sale	158.43	2,500	396,075	99,711	Jan 17 07:37 PM
Douglas Robert Andrew	President and COO ResMed Inc.	Jan 15	Sale	158.43	1,264	200,256	150,780	Jan 17 05:44 PM
Farrell Michael J.	Chief Executive Officer	Jan 13	Option Exercise	43.63	6,651	290,183	361,351	Jan 14 07:34 PM
Farrell Michael J.	Chief Executive Officer	Jan 13	Sale	157.43	6,651	1,047,054	354,700	Jan 14 07:34 PM
PENDARVIS DAVID	Chief Administrative Officer	Jan 03	Option Exercise	58.24	4,739	275,999	135,303	Jan 06 04:16 PM
PENDARVIS DAVID	Chief Administrative Officer	Jan 03	Sale	155.25	4,739	735,730	130,564	Jan 06 04:16 PM
Hollingshead James	President, Sleep Business	Jan 02	Sale	155.40	1,200	186,480	93,174	Jan 06 12:46 PM
Sodhi Rajwant	President, SaaS Business	Jan 02	Sale	155.40	1,350	209,790	38,520	Jan 06 12:44 PM
Douglas Robert Andrew	President and COO ResMed Inc.	Dec 16	Sale	154.71	1,302	201,432	152,044	Dec 18 03:42 PM
Sandercock Brett	Chief Financial Officer	Dec 16	Sale	154.71	2,500	386,775	102,211	Dec 18 12:41 PM
Farrell Michael J.	Chief Executive Officer	Dec 09	Option Exercise	43.63	6,651	290,183	361,351	Dec 11 04:31 PM
Farrell Michael J.	Chief Executive Officer	Dec 09	Sale	149.64	6,651	995,282	354,700	Dec 11 04:31 PM
PENDARVIS DAVID	Chief Administrative Officer	Dec 03	Option Exercise	58.24	4,739	275,999	134,943	Dec 04 09:19 PM
PENDARVIS DAVID	Chief Administrative Officer	Dec 03	Sale	148.94	4,739	705,827	130,564	Dec 04 09:19 PM
Hollingshead James	President, Sleep Business	Dec 02	Option Exercise	58.24	800	46,592	95,974	Dec 04 07:45 PM
Hollingshead James	President, Sleep Business	Dec 02	Sale	149.89	1,600	239,824	94,374	Dec 04 07:45 PM
Sodhi Rajwant	President, SaaS Business	Dec 02	Sale	149.89	1,350	202,352	39,870	Dec 04 06:23 PM
Farrell Michael J.	Chief Executive Officer	Nov 26	Sale	149.26	1,370	204,489	0	Nov 26 08:36 PM
Sandercock Brett	Chief Financial Officer	Nov 26	Sale	147.00	2,500	367,500	104,711	Nov 27 07:55 PM
McHale Richard	President, RC Business	Nov 25	Sale	146.10	3,000	438,285	20,670	Nov 26 06:28 PM
Douglas Robert Andrew	President and COO ResMed Inc.	Nov 18	Sale	146.70	1,360	199,512	154,026	Nov 20 04:08 PM
Hollingshead James	President, Sleep Business	Nov 15	Option Exercise	58.24	21,755	1,267,011	102,387	Nov 18 06:50 PM
Hollingshead James	President, Sleep Business	Nov 15	Sale	146.35	20,038	2,932,561	82,349	Nov 18 06:50 PM
Farrell Michael J.	Chief Executive Officer	Nov 11	Option Exercise	43.63	6,651	290,183	320,067	Nov 13 07:47 PM
PENDARVIS DAVID	Chief Administrative Officer	Nov 11	Option Exercise	57.76	1,731	99,983	119,440	Nov 13 08:41 PM
Farrell Michael J.	Chief Executive Officer	Nov 11	Sale	143.94	6,651	957,337	313,416	Nov 13 07:47 PM
WAREHAM JOHN P	Director	Nov 04	Option Exercise	58.24	10,956	638,077	18,356	Nov 05 02:57 PM
PENDARVIS DAVID	Chief Administrative Officer	Nov 04	Option Exercise	52.02	4,367	227,171	128,781	Nov 05 07:47 PM
PENDARVIS DAVID	Chief Administrative Officer	Nov 04	Sale	147.85	4,367	645,661	124,414	Nov 05 07:47 PM
WAREHAM JOHN P	Director	Nov 04	Sale	147.89	10,956	1,620,238	12,400	Nov 05 02:57 PM
WAREHAM JOHN P	Director	Nov 01	Option Exercise	58.24	9,536	555,377	21,936	Nov 05 02:57 PM
Hollingshead James	President, Sleep Business	Nov 01	Option Exercise	58.24	800	46,592	88,646	Nov 05 03:23 PM
Hollingshead James	President, Sleep Business	Nov 01	Sale	148.92	1,600	238,272	87,046	Nov 05 03:23 PM
Sodhi Rajwant	President, SaaS Business	Nov 01	Sale	148.92	1,350	201,042	34,552	Nov 05 03:19 PM
WAREHAM JOHN P	Director	Nov 01	Sale	148.15	9,536	1,412,730	12,400	Nov 05 02:57 PM
Sandercock Brett	Chief Financial Officer	Oct 30	Sale	145.95	3,000	437,850	72,690	Nov 01 02:01 PM
Douglas Robert Andrew	President and COO ResMed Inc.	Oct 15	Option Exercise	43.63	3,302	144,066	48,716	Oct 16 05:57 PM
Douglas Robert Andrew	President and COO ResMed Inc.	Oct 15	Sale	130.25	3,302	430,086	45,414	Oct 16 05:57 PM
Douglas Robert Andrew	President and COO ResMed Inc.	Oct 15	Sale	130.25	774	100,814	147,519	Oct 16 05:57 PM
Farrell Michael J.	Chief Executive Officer	Oct 14	Option Exercise	43.63	6,651	290,183	310,975	Oct 15 02:33 PM
Farrell Michael J.	Chief Executive Officer	Oct 14	Sale	129.83	6,651	863,493	304,324	Oct 15 02:33 PM
PENDARVIS DAVID	Chief Administrative Officer	Oct 03	Option Exercise	52.02	4,367	227,171	126,618	Oct 04 04:16 PM
PENDARVIS DAVID	Chief Administrative Officer	Oct 03	Sale	128.62	4,367	561,684	122,251	Oct 04 04:16 PM
Hollingshead James	President, Sleep Business	Oct 01	Option Exercise	58.24	800	46,592	86,901	Oct 02 01:46 PM
Hollingshead James	President, Sleep Business	Oct 01	Sale	135.13	1,600	216,208	85,301	Oct 02 01:46 PM
Sodhi Rajwant	President, SaaS Business	Oct 01	Sale	135.13	1,350	182,426	33,357	Oct 02 05:31 PM
Sandercock Brett	Chief Financial Officer	Sep 30	Sale	134.14	3,000	402,420	73,145	Oct 02 12:22 PM
Douglas Robert Andrew	President and COO ResMed Inc.	Sep 16	Option Exercise	43.63	3,307	144,284	48,721	Sep 17 02:52 PM
Douglas Robert Andrew	President and COO ResMed Inc.	Sep 16	Sale	131.63	757	99,644	148,293	Sep 17 02:52 PM
Douglas Robert Andrew	President and COO ResMed Inc.	Sep 16	Sale	131.63	3,307	435,300	45,414	Sep 17 02:52 PM
Farrell Michael J.	Chief Executive Officer	Sep 09	Option Exercise	43.63	6,651	290,183	310,975	Sep 10 02:11 PM
Farrell Michael J.	Chief Executive Officer	Sep 09	Sale	137.38	6,651	913,714	304,324	Sep 10 02:11 PM
PENDARVIS DAVID	Chief Administrative Officer	Sep 03	Option Exercise	52.02	4,367	227,171	126,618	Sep 04 04:58 PM
Hollingshead James	President, Sleep Business	Sep 03	Option Exercise	58.24	800	46,592	87,702	Sep 04 05:16 PM
PENDARVIS DAVID	Chief Administrative Officer	Sep 03	Sale	138.11	4,367	603,126	122,251	Sep 04 04:58 PM
Sodhi Rajwant	President, SaaS Business	Sep 03	Sale	138.11	1,350	186,449	34,707	Sep 04 05:21 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience